Hans Ivar Robinson • 1967 • Snarøya • 7 roles • 6 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
B BIRK INVESTMENT AS	Managing Director/CEO	-	55,766,217	100 % directly
B BIRK VENTURE AS	Managing Director/CEO	-	16,708,536	100 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
B BIRK INVESTMENT AS	Chairman	-	55,766,217	100 % directly
B BIRK VENTURE AS	Chairman	-	16,708,536	100 % indirectly
N NEXTERA AS	Chairman	12,650,318	14,802,788	16.83 % indirectly
Z ZELLUNA IMMUNOTHERAPY AS	Board Member	7,891,998	123,683,924	9.7 % indirectly
Q QUALITY REGNSKAP AS	Board Member	5,861,578	2,280,814	-

Last update: Feb 28, 2024

Related industries2

Professional, scientific and technical activities
Financial and insurance activities

Direct relationships5

AT
Anders Tuv1978
ZELLUNA IMMUNOTHERAPY AS, NEXTERA AS
BK
Bent Karsten Jakobsen1959
ZELLUNA IMMUNOTHERAPY AS, NEXTERA AS
ER
Eirin Guldsten Robinson1973
BIRK INVESTMENT AS, BIRK VENTURE AS
RJ
Rolf Jørgen Bjelke1967
QUALITY REGNSKAP AS
PO
Per-Oluf Olsen1956
NEXTERA AS

Shares owned by Hans Ivar Robinson

Name	Share class	Total operating income	Total equity	Share
B BIRK INVESTMENT AS	Ordinære aksjer	0	55,766,217	100 % directly
B BIRK VENTURE AS		0	16,708,536	100 % indirectly
U UNAVAR AS	Ordinære aksjer	0	1,387,572	50 % directly
N NEXTERA AS		12,650,318	14,802,788	16.83 % indirectly
Z ZELLUNA IMMUNOTHERAPY AS		7,891,998	123,683,924	9.7 % indirectly
A APIM THERAPEUTICS AS		0	60,430,622	2.96 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024